# Hoyne Bancorp, Inc.: financial statements, quarterly

HYNE · Nasdaq · CIK 2073153 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hyne.md) · [Financials](/companies/hyne/financials.md) · [Filings](/companies/hyne/filings.md) · [Insiders](/companies/hyne/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hyne/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $k | [(247)](/filings/0001104659-25-111398.md) | [(247) d](/filings/0001104659-26-035156.md) | [(76.5)](/filings/0001104659-26-059252.md) | [72.0](/filings/0001104659-26-094047.md) | [25.5](/filings/0001104659-25-111398.md) | [(236) d](/filings/0001104659-26-035156.md) | [(56.2)](/filings/0001104659-26-059252.md) | [50.0](/filings/0001104659-26-094047.md) |
| Net income | $k | [(397)](/filings/0001104659-25-111398.md) | [(422) d](/filings/0001104659-26-035156.md) | [(166)](/filings/0001104659-26-059252.md) | [118](/filings/0001104659-26-094047.md) | [70.1](/filings/0001104659-25-111398.md) | [202 d](/filings/0001104659-26-035156.md) | [(118)](/filings/0001104659-26-059252.md) | [96.0](/filings/0001104659-26-094047.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.02)](/filings/0001104659-26-059252.md) | [0.01](/filings/0001104659-26-094047.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.02)](/filings/0001104659-26-059252.md) | [0.01](/filings/0001104659-26-094047.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | not reported | not reported | not reported | [450](/filings/0001104659-26-035156.md) | not reported | not reported | [455](/filings/0001104659-25-111398.md) | [489](/filings/0001104659-26-094047.md) | [477](/filings/0001104659-26-059252.md) | [480](/filings/0001104659-26-094047.md) |
| Total liabilities | $m | not reported | not reported | not reported | [364](/filings/0001104659-26-035156.md) | not reported | not reported | [365](/filings/0001104659-25-111398.md) | [328](/filings/0001104659-26-094047.md) | [316](/filings/0001104659-26-059252.md) | [319](/filings/0001104659-26-094047.md) |
| Shareholders' equity | $m | [87.8](/filings/0001104659-26-035156.md) | [85.8](/filings/0001104659-25-111398.md) | [88.5](/filings/0001104659-25-111398.md) | [85.8](/filings/0001104659-26-094047.md) | [87.9](/filings/0001104659-26-094047.md) | [88.9](/filings/0001104659-26-094047.md) | [90.1](/filings/0001104659-25-111398.md) | [161](/filings/0001104659-26-094047.md) | [161](/filings/0001104659-26-094047.md) | [161](/filings/0001104659-26-094047.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,455) d](/filings/0001104659-26-035156.md) | [905](/filings/0001104659-26-059252.md) | [1,826 d](/filings/0001104659-26-094047.md) | [(2,756) d](/filings/0001104659-25-111398.md) | [1,270 d](/filings/0001104659-26-035156.md) | [(821)](/filings/0001104659-26-059252.md) | [(471) d](/filings/0001104659-26-094047.md) |
| Capital expenditure | $k | [254 d](/filings/0001104659-26-035156.md) | [172](/filings/0001104659-26-059252.md) | [222 d](/filings/0001104659-26-094047.md) | [44.0 d](/filings/0001104659-25-111398.md) | [605 d](/filings/0001104659-26-035156.md) | [48.6](/filings/0001104659-26-059252.md) | [183 d](/filings/0001104659-26-094047.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,458](/filings/0001104659-26-059252.md) | [7,461](/filings/0001104659-26-094047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,096,938 at 2026-08-11, from the cover of the [10-Q filed 2026-08-11](/filings/0001104659-26-094047.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.